Overview

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Status:
COMPLETED
Trial end date:
2023-11-13
Target enrollment:
Participant gender:
Summary
combination deucravacitinib and enstilar foam
Phase:
PHASE4
Details
Lead Sponsor:
Psoriasis Treatment Center of Central New Jersey
Treatments:
Betamethasone
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
deucravacitinib